|
1
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the united states in 2008–2012. Neuro Oncol. 17
Suppl 4:iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McNeill KA: Epidemiology of brain tumors.
Neurol Clin. 34:981–998. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fabbro M, Zhou BB, Takahashi M, Sarcevic
B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y and
Khanna KK: Cdk1/Erk2- and Plk1-dependent phosphorylation of a
centrosome protein, Cep55, is required for its recruitment to
midbody and cytokinesis. Dev Cell. 9:477–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao WM, Seki A and Fang G: Cep55, a
microtubule-bundling protein, associates with centralspindlin to
control the midbody integrity and cell abscission during
cytokinesis. Mol Biol Cell. 17:3881–3896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee HH, Elia N, Ghirlando R,
Lippincott-Schwartz J and Hurley JH: Midbody targeting of the ESCRT
machinery by a noncanonical coiled coil in CEP55. Science.
322:576–580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carlton JG, Agromayor M and Martin-Serrano
J: Differential requirements for Alix and ESCRT-III in cytokinesis
and HIV-1 release. Proc Natl Acad Sci USA. 105:pp. 10541–10546.
2008; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carlton JG and Martin-Serrano J: Parallels
between cytokinesis and retroviral budding: A role for the ESCRT
machinery. Science. 316:1908–1912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeffery J, Neyt C, Moore W, Paterson S,
Bower NI, Chenevix-Trench G, Verkade H, Hogan BM and Khanna KK:
Cep55 regulates embryonic growth and development by promoting Akt
stability in zebrafish. FASEB J. 29:1999–2009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeffery J, Sinha D, Srihari S, Kalimutho M
and Khanna KK: Beyond cytokinesis: The emerging roles of CEP55 in
tumorigenesis. Oncogene. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shiraishi T, Terada N, Zeng Y, Suyama T,
Luo J, Trock B, Kulkarni P and Getzenberg RH: Cancer/Testis
Antigens as potential predictors of biochemical recurrence of
prostate cancer following radical prostatectomy. J Transl Med.
9:1532011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh PK, Srivastava AK, Rath SK, Dalela
D, Goel MM and Bhatt ML: Expression and clinical significance of
Centrosomal protein 55 (CEP55) in human urinary bladder
transitional cell carcinoma. Immunobiology. 220:103–108. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Niu C, He W, Hou T, Sun X, Xu L
and Zhang Y: Upregulation of centrosomal protein 55 is associated
with unfavorable prognosis and tumor invasion in epithelial ovarian
carcinoma. Tumour Biol. 37:6239–6254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
French PJ, Swagemakers SM, Nagel JH,
Kouwenhoven MC, Brouwer E, van der Spek P, Luider TM, Kros JM, van
den Bent MJ and Sillevis Smitt PA: Gene expression profiles
associated with treatment response in oligodendrogliomas. Cancer
Res. 65:11335–11344. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murat A, Migliavacca E, Gorlia T, Lambiv
WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven
MC, et al: Stem cell-related ‘self-renewal’ signature and high
epidermal growth factor receptor expression associated with
resistance to concomitant chemoradiotherapy in glioblastoma. J Clin
Oncol. 26:3015–3024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun L, Hui AM, Su Q, Vortmeyer A,
Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey
R, et al: Neuronal and glioma-derived stem cell factor induces
angiogenesis within the brain. Cancer Cell. 9:287–300. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Casimiro MC, Crosariol M, Loro E, Li Z and
Pestell RG: Cyclins and cell cycle control in cancer and disease.
Genes Cancer. 3:649–657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hemmings BA and Restuccia DF: PI3K-PKB/Akt
pathway. Cold Spring Harb Perspect Biol. 4:a0111892012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Mei Q, Zhao J, Dai Y and Fu Q:
Suppression of CEP55 reduces cell viability and induces apoptosis
in human lung cancer. Oncol Rep. 36:1939–1945. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa
JR and Walsh K: Cell cycle withdrawal promotes myogenic induction
of Akt, a positive modulator of myocyte survival. Mol Cell Biol.
19:5073–5082. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun
J, Han K, Shen J, Zhu M, Lin Z, et al: Centrosomal protein of 55
regulates glucose metabolism, proliferation and apoptosis of glioma
cells via the Akt/mTOR signaling pathway. J Cancer. 7:1431–1440.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W,
Xie K, Tang J, Zhang X, Wang L and Xu Z: CEP55 contributes to human
gastric carcinoma by regulating cell proliferation. Tumour Biol.
35:4389–4399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ,
Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, et al: FLJ10540-elicited
cell transformation is through the activation of PI3-kinase/AKT
pathway. Oncogene. 26:4272–4283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Jin T, Dai X and Xu J:
Lentivirus-mediated knockdown of CEP55 suppresses cell
proliferation of breast cancer cells. Biosci Trends. 10:67–73.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen CH, Shiu LY, Su LJ, Huang CY, Huang
SC, Huang CC, Yin YF, Wang WS, Tsai HT, Fang FM, et al: FLJ10540 is
associated with tumor progression in nasopharyngeal carcinomas and
contributes to nasopharyngeal cell proliferation, and metastasis
via osteopontin/CD44 pathway. J Transl Med. 10:932012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nguyen-Ba G and Vasseur P: Epigenetic
events during the process of cell transformation induced by
carcinogens (review). Oncol Rep. 6:925–932. 1999.PubMed/NCBI
|
|
30
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hui L, Yang N, Yang H, Guo X and Jang X:
Identification of biomarkers with a tumor stage-dependent
expression and exploration of the mechanism involved in laryngeal
squamous cell carcinoma. Oncol Rep. 34:2627–2635. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alt JR, Gladden AB and Diehl JA: p21(Cip1)
Promotes cyclin D1 nuclear accumulation via direct inhibition of
nuclear export. J Biol Chem. 277:8517–8523. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brehm A, Miska EA, McCance DJ, Reid JL,
Bannister AJ and Kouzarides T: Retinoblastoma protein recruits
histone deacetylase to repress transcription. Nature. 391:597–601.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Archer SY, Johnson J, Kim HJ, Ma Q, Mou H,
Daesety V, Meng S and Hodin RA: The histone deacetylase inhibitor
butyrate downregulates cyclin B1 gene expression via a
p21/WAF-1-dependent mechanism in human colon cancer cells. Am J
Physiol Gastrointest Liver Physiol. 289:G696–G703. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
